4 results  1 of 1 

1 Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
J Korean Med Sci.2021;36(16):e105.  Published online 2021 April 5     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e105
      
2 Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
Mohammad Hossein Khosravi, Seyed Moayed Alavian
J Korean Med Sci.2016;31(5):824-824.   Published online 2016 March 22     DOI: http://dx.doi.org/10.3346/jkms.2016.31.5.824
      
3 Reactivation of Hepatitis B Virus in Patients with Rheumatologic Disease Treated with Biologic Disease Modifying Anti-rheumatic Drugs: Screening and Treatment
Jung Il Lee
J Rheum Dis.2015;22(5):282-287.   Published online 2015 October 31     DOI: http://dx.doi.org/10.4078/jrd.2015.22.5.282
   
4 Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
J Korean Med Sci.2015;30(11):1618-1624.   Published online 2015 October 16     DOI: http://dx.doi.org/10.3346/jkms.2015.30.11.1618
      

 1 of 1